News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

“It has been a great privilege to be part of a project which empowers women to prioritise their health"

Following the success of 2022’s event, the Oncology & Precision Medicine Conference once again took place over two days to facilitate a more in-depth programme, with 149 delegates meeting...

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the ...

Following publication in prestigious journal Nature Communications, Huddersfield researchers have been awarded an EPSRC grant to further their studies in the selectivity of compounds in canc...

Martin Slater, Director at Cresset Discovery reviews our recent published collaboration with University of South Australia

For the first time in 2022, the Oncology & Precision Medicine Conferences were a two-day event with 120 delegates coming together to discuss the current oncology landscape and the future of ...

An academic from Teesside University has been awarded £100,000 to fund essential brain cancer research, which aims to advance diagnosis and treatments.

A new Liverpool led study, published in Gut, has identified how immune cells in the body can promote the regrowth of cancer cells after chemotherapy withdrawal. These findings will help impr...

Could research which focusses on capturing and characterising “circulating tumour cells” (CTCs) revolutionise the diagnosis and treatment of cancer?

Researchers in Liverpool have begun recruiting patients to a ‘first-in-human’ clinical trial of personalised ‘vaccines’ that aim to reduce the risk of head and neck cancers – which...

Aptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, today announces that they have en...

Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners